ID
45801
Beschrijving
Principal Investigator: Joseph DeRisi, PhD, Howard Hughes Medical Institute, University of California, San Francisco, USA MeSH: Encephalitis,Meningitis,Myelitis https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001067 This is a prospective observational study seeking to identify pathogens in cases of unexplained neurological disease, particularly those in which there is a presumed infectious cause. This next generation analytical approach will hopefully allow for rapid identification of foreign genomic material, and through a sophisticated bioinformatics pipeline developed in the DeRisi lab, these foreign genomic sequences can be aligned to all known sequences in publicly available databases (i.e. GenBank) which may allow for identification of novel pathogens or known pathogens that are not frequently tested for as part of standard diagnostic work-ups.
Link
Trefwoorden
Versies (1)
- 23-06-23 23-06-23 - Chiara Middel
Houder van rechten
Joseph DeRisi, PhD, Howard Hughes Medical Institute, University of California, San Francisco, USA
Geüploaded op
23 juni 2023
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs001067 Metagenomic Deep Sequencing in Meningitis and Encephalitis
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- This subject consent file contains subject IDs, consent group information, subject aliases, and affection status meningitis and/or encephalitis.
- This subject sample mapping file contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use.
- This subject phenotype data table includes sex and disease onset age.
- This sample attributes data table includes body site where sample was collected, analyte type, tumor status, and histological type.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- This subject consent file contains subject IDs, consent group information, subject aliases, and affection status meningitis and/or encephalitis.
- This subject sample mapping file contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use.
- This subject phenotype data table includes sex and disease onset age.
- This sample attributes data table includes body site where sample was collected, analyte type, tumor status, and histological type.
C0680251 (UMLS CUI [1,2])
C4288071 (UMLS CUI [1,2])
C0205494 (UMLS CUI [1,3])
C0039082 (UMLS CUI [1,4])
C3844350 (UMLS CUI [1,5])
C0678226 (UMLS CUI [1,6])
C0004364 (UMLS CUI [1,7])
C0009450 (UMLS CUI [1,8])
C0001675 (UMLS CUI [1,9])
C0008059 (UMLS CUI [1,10])
C0033167 (UMLS CUI [1,2])